Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02831764
What this trial is testing

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 722
Large-scale testing (Phase 3)Study completedNCT01721109
What this trial is testing

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 50
Testing effectiveness (Phase 2)Study completedNCT03099005
What this trial is testing

Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain

Who this might be right for
CannabisHIV NeuropathyPain Syndrome
University of California, San Diego 5
Testing effectiveness (Phase 2)Study completedNCT04143594
What this trial is testing

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Who this might be right for
HIV-1-infection
Gilead Sciences 183
Early research (Phase 1)Study completedNCT00002402
What this trial is testing

AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

Who this might be right for
HIV Infections
VaxGen 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05546242
What this trial is testing

Improving HIV-1 Control in Africa with Long Acting Antiretrovirals

Who this might be right for
HIV-1-infection
MRC/UVRI and LSHTM Uganda Research Unit 540
Testing effectiveness (Phase 2)Study completedNCT00089583
What this trial is testing

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 110
Post-approval studies (Phase 4)Study completedNCT00000894
What this trial is testing

Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT03098654
What this trial is testing

Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania

Who this might be right for
Human Immunodeficiency VirusDiabetes Mellitus, Type 2Hypertension
Medical University of South Carolina 214
Testing effectiveness (Phase 2)Study completedNCT05005156
What this trial is testing

Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV

Who this might be right for
Covid19
Fundación Huésped 155
Large-scale testing (Phase 3)Looking for participantsNCT07266831
What this trial is testing

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC 570
Early research (Phase 1)Study completedNCT04757974
What this trial is testing

Low-dose Fostemsavir Extended Release Relative Bioavailability Study

Who this might be right for
HIV Infections
ViiV Healthcare 32
Early research (Phase 1)Study completedNCT00270218
What this trial is testing

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 66
Large-scale testing (Phase 3)Study completedNCT00130247
What this trial is testing

Tuberculosis Treatment Shortening Trial

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 394
Testing effectiveness (Phase 2)Study completedNCT03512249
What this trial is testing

Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

Who this might be right for
Tuberculosis, Pulmonary
International AIDS Vaccine Initiative 831
Testing effectiveness (Phase 2)WithdrawnNCT01443117
What this trial is testing

Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women

Who this might be right for
Pneumococcal InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT03145753
What this trial is testing

Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03)

Who this might be right for
HIV InfectionHCV Coinfection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 7,989
Testing effectiveness (Phase 2)Study completedNCT00892437
What this trial is testing

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 85
Early research (Phase 1)Study completedNCT04507321
What this trial is testing

Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254

Who this might be right for
HIV Infections
ViiV Healthcare 5
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation